Br J Pharmacol 179(4):557570 Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB et al (2018a) Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Frequently asked questions Does microdosing GLP-1 for autoimmune conditions cause weight loss
A stroke, a severe infection, or a catastrophic allergic reaction to an unknown substance is a possible outcome
It has been shown that Nrf2 is related to mTOR and our data supported the notion that sulforaphane exerts neuronal protective effects via activating Nrf2 and mTOR
Peptides Lab UK supplies bacteriostatic water as a sterile, laboratory-grade reconstitution solvent specifically formatted for use with lyophilised research peptide preparations
Effect of a multidisciplinary team approach in patients with diabetic foot ulcers on major adverse limb events (MALEs): systematic review and meta-analysis for the development of the Italian guidelines for the treatment of diabetic foot syndrome